SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment. - Wikidata - wikimedia - TriplyDB

SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.

SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.

http://www.wikidata.org/entity/Q37358513

about

GRIM-19 Restricts HCV Replication by Attenuating Intracellular Lipid Accumulation.Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.

P2860

Q37747068-05F9E2F1-8AB3-4779-98CF-181BFA927A28 Q47552631-70D153C4-141E-44F5-B0B7-3665CC6D5883

P2860

SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.

http://www.wikidata.org/entity/Q37358513

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

SOCS3 mRNA expression and poly ...... notype 3a IFN-based treatment.

@en

SOCS3 mRNA expression and poly ...... notype 3a IFN-based treatment.

@nl

type

label

SOCS3 mRNA expression and poly ...... notype 3a IFN-based treatment.

@en

SOCS3 mRNA expression and poly ...... notype 3a IFN-based treatment.

@nl

prefLabel

SOCS3 mRNA expression and poly ...... notype 3a IFN-based treatment.

@en

SOCS3 mRNA expression and poly ...... notype 3a IFN-based treatment.

@nl

P1433

Q37358513-7D84A984-5CD8-4CB8-8551-BF6E680A0502

P1476

Q37358513-7E7131F9-9CF0-4001-B316-E30407B97EED

P2093

Q37358513-075679FD-14AE-4ACE-86D3-FEC8015DEDAE

Q37358513-20FEDEE0-22FF-49B8-A14C-29B9A60F2276

Q37358513-5DFD9581-BB80-4CCC-804C-083F344B463B

Q37358513-84FEA62F-1E91-438A-9553-957A06698D25

Q37358513-AE3C9D44-DADC-4311-8F1A-DF48D0BA3228

P2860

Q37358513-02EBBD51-CFB8-4416-8B97-C6EA0643E071

Q37358513-1EBD940D-BD24-4A25-8695-BE305CD11C76

Q37358513-25AD7598-475D-4F2F-9BDC-358178A4333A

Q37358513-273EBD43-3C86-4C47-AABD-ABE413B93C44

Q37358513-36FBA2C6-DF7E-420F-A5F5-CF67FD5C87FE

Q37358513-43603555-9D7E-4081-B608-0E06E1904C57

Q37358513-4737CBE3-B41C-405E-B42E-898FA7A74269

Q37358513-4B28BD73-D95E-48DD-BA9C-261BD4D6AFB0

Q37358513-5BA91A52-28F4-4803-826C-71FE36B0A49B

Q37358513-5C241F71-476C-4607-9610-E458713B6415

P2888

Q37358513-21C62391-7525-4CFD-8302-E68BC9F34607

P304

Q37358513-29A58CB1-57AB-48BC-8C75-F976F2F6C0D1

P31

Q37358513-7312284D-4699-4323-A2E5-B3EEE13E02D3

P356

Q37358513-446E18E8-62C2-4762-9B62-34398110C973

P433

Q37358513-A51E6419-91C9-45E1-A0D8-AD81AB607752

P478

Q37358513-0F6BB4AC-4CA6-458E-A514-EE48ACE295CE

P50

Q37358513-0C11AB56-0F82-4B2E-A9BA-DE904AE9742C

P577

Q37358513-5182670F-EA60-468D-97E2-83B25BB3176B

P6179

Q37358513-A23D7CC3-539B-4CBB-8B9C-CF98765D0B66

P698

Q37358513-ACAC0D0E-C28F-4C07-8B4C-8A778962E0C8

P932

Q37358513-0A3DF949-545E-4E98-AF96-5DADC9821FFC

P356

S40064-016-3506-5

P1433

P1476

SOCS3 mRNA expression and poly ...... enotype 3a IFN-based treatment

@en

P2093

Bushra Mubarak

http://www.w3.org/2001/XMLSchema#string

Humeira Naeemi

http://www.w3.org/2001/XMLSchema#string

Nadeem Afzal

http://www.w3.org/2001/XMLSchema#string

Rabia Aslam

http://www.w3.org/2001/XMLSchema#string

Syed Mohsin Raza

http://www.w3.org/2001/XMLSchema#string

P2860

Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

Determinants of viral clearance and persistence during acute hepatitis C virus infection

SOCS proteins: negative regulators of cytokine signaling

Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan

Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection.

Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.

Altered T cell signalling in ageing.

Peginterferon and ribavirin treatment for hepatitis C virus infection

Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91

P2888

s40064-016-3506-5

P304

1826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-016-3506-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024155808

http://www.w3.org/2001/XMLSchema#string

P698

27818864

http://www.w3.org/2001/XMLSchema#string

P932

5074986

http://www.w3.org/2001/XMLSchema#string